Sherrill B, Amonkar M, Sherif B, Maltzman J, O'Rourke L, Johnston S. An exploration of the association of qol scores with tumor progression status in first-line hr+, her2+ mbc patients treated with lapatinib plus letrozole or letrozole alone. Poster presented at the 32nd San Antoniio Breast Cancer Symposium Annual Meeting; December 14, 2009.